DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 2.75% to $153.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.37% to 6,796.29 and the Dow Jones Industrial Average rising 0.48% to 47,311.00.
The stock's rise snapped a two-day losing streak.
Biogen Inc. closed 14.38% short of its 52-week high of $179.20, which the company reached on November 6th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.46% to $186.00, Pfizer Inc. $(PFE)$ rose 1.28% to $24.61, and AbbVie Inc. $(ABBV)$ rose 0.41% to $216.77.
Trading volume (1.8 M) eclipsed its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 5, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 05, 2025 17:06 ET (22:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.